Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
基本信息
- 批准号:10413022
- 负责人:
- 金额:$ 103.15万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-08 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAdherenceAlgorithmsAsian AmericansAsian populationAutomobile DrivingBehaviorBiologicalBiologyBody SizeBreast Cancer PatientCaliforniaCancer BiologyCancer PrognosisCellsCharacteristicsChineseClinicalCohort StudiesComplementary and alternative medicineDataDietary intakeElectronic Health RecordEpidemiologyEthnic OriginEthnic groupGeneticHealth PromotionHealth behaviorHealthcare SystemsHeterogeneityImmigrationImmuneImmune responseImmunobiologyImmunogenomicsImmunologic ReceptorsIndividualJapaneseKnowledgeLife StyleMaintenanceMalignant NeoplasmsMammary NeoplasmsModelingNeighborhoodsOutcomePathway interactionsPatient Self-ReportPatientsPatternPhenotypePlantsPopulationPopulation GroupPopulation HeterogeneityPrevalencePrognostic FactorRaceResearchResourcesSamplingSiteSocial EnvironmentSocial supportSocioeconomic StatusSurvival RateThe Cancer Genome AtlasTimeTissue SampleTissuesTranslatingTreatment FactorTreatment outcomeTumor TissueTumor-infiltrating immune cellsUnited StatesWomanWomen&aposs Groupanti-tumor immune responsebaseblack womenbreast cancer diagnosisbreast cancer family registrybreast cancer survivalcancer health disparitycancer immunobiologycancer immunotherapycancer survivalchemotherapycohortcomparison groupcontextual factorsdata registrydisorder riskethnic differenceexperiencefollow-uphealth care availabilityhormone therapyimprovedinsightlifestyle factorsmalignant breast neoplasmmortalitymulti-ethnicneoplasm registryprognosticprognostic assaysprognostic indicatorprotective factorsracial and ethnicracial and ethnic disparitiessocial culturetissue archivetranscriptome sequencingtreatment adherencetumortumor microenvironment
项目摘要
Abstract
Asian American women experience more favorable cancer survival than other US racial/ethnic groups, even
after accounting for known prognostic indicators. Breast cancer, which follows this pattern, is a useful model for
understanding factors contributing to this intriguing survival advantage, given that it is the most common
cancer in Asian American women, and has established clinical, biological/genetic, and lifestyle prognostic
factors. Thus, studying the breast cancer survival advantage in Asian American women has the potential to
identify protective factors that may benefit all patients. We propose to investigate multilevel factors (health
behaviors and contextual factors, clinical characteristics, treatment, and tumor immune response) in relation to
overall and breast cancer-specific mortality in Asian American breast cancer cases. However, the Asian
American population is heterogeneous, with lifestyle factors and disease risks (e.g., breast cancer survival
rates) varying by specific ethnicity and by immigration status. Many studies have shown the importance of
population disaggregation to uncovering meaningful differences among Asian American ethnic groups, but no
single study to date includes adequate Asian American ethnic group population samples. To overcome this
limitation, we will conduct the proposed research in integrated data and biospecimens from four established
cohort studies enriched with Asian American breast cancer cases. These studies together include 4,219 Asian
American patients (1,848 Chinese, 602 Japanese, 1,538 Filipinas) and 5,386 non-Latina White women with
breast cancer as a comparison group. In Specific Aim 1, we will assess contributions of individual-level lifestyle
and health behaviors and multilevel neighborhood social context and sociocultural factors to survival
differences among the Asian American ethnic groups relative to non-Latina Whites. In Specific Aim 2, we will
evaluate how specific treatment factors impact survival for 4,373 Asian Americans compared to 4,373 non-
Latina Whites, taking advantage of electronic health record data from an equal-access healthcare system. In
Specific Aim 3, we will characterize the immune infiltrates in the breast tumor microenvironment from 1,200
Asian American (from Aim 1) and 714 non-Latina White (from TCGA) patients using immunogenomic profiling,
and to determine the associations of immune phenotypes with patient survival among Asian Americans and
with exposure factors from Aim 1. Thus, using existing resources, this study will comprehensively assess
factors including health behaviors and neighborhood context, lifestyle, treatment, tumor immuno-biology, and
their contributions to the survival advantage in Asian American women. The proposed study makes efficient
use of data from numerous breast cancer studies to gain insight for strategies that may advance knowledge
about the management of breast cancer for all women.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scarlett L Gomez其他文献
Scarlett L Gomez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scarlett L Gomez', 18)}}的其他基金
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
9973785 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
10643861 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Insights from Asian Populations into Disparities in Breast Cancer Prognosis and Outcomes
亚洲人群对乳腺癌预后和结果差异的见解
- 批准号:
10186715 - 财政年份:2020
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
10176166 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
9802764 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
10410413 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)
用于了解和改善生存体验的癌症登记处 (CRUISE)
- 批准号:
10651763 - 财政年份:2019
- 资助金额:
$ 103.15万 - 项目类别:
Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men
项目 1:非裔美国男性的多层次社会压力源和侵袭性前列腺癌
- 批准号:
10249993 - 财政年份:2018
- 资助金额:
$ 103.15万 - 项目类别:
Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men
项目 1:非裔美国男性的多层次社会压力源和侵袭性前列腺癌
- 批准号:
9982835 - 财政年份:2018
- 资助金额:
$ 103.15万 - 项目类别:
Project 1: Multilevel Social Stressors and Aggressive Prostate Cancer in African American Men
项目 1:非裔美国男性的多层次社会压力源和侵袭性前列腺癌
- 批准号:
10447153 - 财政年份:2018
- 资助金额:
$ 103.15万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 103.15万 - 项目类别:
Fellowship Programs














{{item.name}}会员




